Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Annual Follow-Up Study

NCT00006421 · clinicaltrials.gov ↗

COMPLETED

Status

200

Enrollment

NIH

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: 2-Fluorodeoxyglucose

Sponsor

National Cancer Institute (NCI)